ORKA Oruka Therapeutics, Inc.
Nasdaq · SEC CIK 907654 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $333.55M 38 sales by 7 insiders
- Filings on record
- 105 since 2021-11-23, latest 2026-09-21 17:38
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| Dambkowski Carl | Dir | — | $8.65M |
| Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| Quinlan Paul T | GC | — | $6.76M |
| Goncalves Joana | Chief Medical Off | — | $4.54M |
| Agarwal Arjun | SVP, Fin | — | $4.33M |
| Sandler Laura Lee | COO | — | $1.94M |
| Edwards Larry Todd | Chief Commercial Off | — | — |
Transactions 96
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-21 17:38 | 2026-09-21 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale | $95.75 | -533 | 14.2K | -4% | -$51.0K |
| DT | 2026-09-21 16:57 | 2026-09-21 | ORKA | Quinlan Paul T | GC | M - OptEx | $7.80 | +10.0K | 40.0K | +33% | +$78.0K |
| DMT | 2026-09-21 16:57 | 2026-09-21 | ORKA | Quinlan Paul T | GC | S - Sale+OE | $93.64 | -10.0K | 30.0K | -25% | -$936.4K |
| DMT | 2026-09-15 19:18 | 2026-09-15 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 39.7K | +21% | +$51.2K |
| DMT | 2026-09-15 19:18 | 2026-09-15 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $92.38 | -7,947 | 31.8K | -20% | -$734.1K |
| DMT | 2026-09-15 19:17 | 2026-09-11 | ORKA | Agarwal Arjun | SVP, Fin | M - OptEx | $15.88 | +9,459 | 24.8K | +62% | +$150.2K |
| DMT | 2026-09-15 19:17 | 2026-09-11+ | ORKA | Agarwal Arjun | SVP, Fin | S - Sale+OE | $92.43 | -10.0K | 14.8K | -40% | -$926.0K |
| 2026-09-15 19:15 | 2026-09-15 | ORKA | Klein Lawrence Otto | CEO, Dir | S - Sale | $95.71 | -2,452 | 923.1K | -0.3% | -$234.7K | |
| 2026-09-15 19:14 | 2026-09-15 | ORKA | Quinlan Paul T | GC | S - Sale | $95.71 | -1,039 | 30.0K | -3% | -$99.4K | |
| 2026-09-15 19:11 | 2026-09-15 | ORKA | Sandler Laura Lee | COO | S - Sale | $95.71 | -906 | 235.5K | -0.4% | -$86.7K | |
| DT | 2026-09-01 18:36 | 2026-09-01 | ORKA | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 241.4K | +2% | +$39.0K |
| DMT | 2026-09-01 18:36 | 2026-09-01 | ORKA | Sandler Laura Lee | COO | S - Sale+OE | $91.82 | -5,000 | 236.4K | -2% | -$459.1K |
| DT | 2026-09-01 18:35 | 2026-09-01 | ORKA | Klein Lawrence Otto | CEO, Dir | M - OptEx | $7.80 | +75.0K | 1.00M | +8% | +$585.0K |
| DMT | 2026-09-01 18:35 | 2026-09-01 | ORKA | Klein Lawrence Otto | CEO, Dir | S - Sale+OE | $91.83 | -75.0K | 925.6K | -7% | -$6.89M |
| D | 2026-08-25 16:25 | 2026-08-24 | ORKA | Edwards Larry Todd | Chief Commercial Off | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| DMT | 2026-08-17 18:09 | 2026-08-17 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 39.7K | +21% | +$51.2K |
| DMT | 2026-08-17 18:09 | 2026-08-17 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $111.84 | -7,000 | 32.7K | -18% | -$782.9K |
| DMT | 2026-08-14 17:52 | 2026-08-14 | ORKA | Quinlan Paul T | GC | M - OptEx | $11.60 | +52.0K | 83.0K | +168% | +$603.0K |
| DMT | 2026-08-14 17:52 | 2026-08-14 | ORKA | Quinlan Paul T | GC | S - Sale+OE | $108.49 | -52.0K | 31.0K | -63% | -$5.64M |
| DMT | 2026-08-14 17:42 | 2026-08-13 | ORKA | Agarwal Arjun | SVP, Fin | M - OptEx | $15.69 | +10.0K | 25.3K | +65% | +$156.9K |
| DMT | 2026-08-14 17:42 | 2026-08-13 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale+OE | $106.66 | -10.0K | 15.3K | -40% | -$1.07M |
| DMT | 2026-07-15 19:36 | 2026-07-15 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 39.7K | +21% | +$51.2K |
| DMT | 2026-07-15 19:36 | 2026-07-15 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $86.28 | -7,000 | 32.7K | -18% | -$603.9K |
| DMT | 2026-07-13 17:09 | 2026-07-13 | ORKA | Agarwal Arjun | SVP, Fin | M - OptEx | $15.69 | +9,999 | 25.3K | +65% | +$156.9K |
| DMT | 2026-07-13 17:09 | 2026-07-13 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale+OE | $84.63 | -9,999 | 15.3K | -40% | -$846.2K |
| DI | 2026-07-01 21:30 | 2026-07-01 | ORKA | Fairmount Funds Management LLC | Dir, 10% | C - Cnv Deriv | — | +3.55M | 4.69M | +314% | — |
| DI | 2026-07-01 21:30 | 2026-07-01 | ORKA | Fairmount Funds Management LLC | Dir, 10% | S - Sale | $84.43 | -3.55M | 1.13M | -76% | -$300.01M |
| DT | 2026-07-01 19:58 | 2026-07-01 | ORKA | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 241.4K | +2% | +$39.0K |
| DMT | 2026-07-01 19:58 | 2026-07-01 | ORKA | Sandler Laura Lee | COO | S - Sale+OE | $94.42 | -5,000 | 236.4K | -2% | -$472.1K |
| MT | 2026-06-22 19:59 | 2026-06-22 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale | $80.95 | -1,587 | 15.3K | -9% | -$128.5K |
| DMT | 2026-06-15 18:57 | 2026-06-12 | ORKA | Agarwal Arjun | SVP, Fin | M - OptEx | $15.88 | +9,459 | 26.8K | +55% | +$150.2K |
| DMT | 2026-06-15 18:57 | 2026-06-12+ | ORKA | Agarwal Arjun | SVP, Fin | S - Sale+OE | $69.72 | -9,854 | 16.9K | -37% | -$687.0K |
| DMT | 2026-06-15 18:54 | 2026-06-15 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 40.7K | +21% | +$51.2K |
| DMT | 2026-06-15 18:54 | 2026-06-15 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $69.28 | -7,947 | 32.7K | -20% | -$550.6K |
| 2026-06-15 18:52 | 2026-06-15 | ORKA | Klein Lawrence Otto | CEO, Dir | S - Sale | $69.69 | -1,729 | 925.6K | -0.2% | -$120.5K | |
| 2026-06-15 18:51 | 2026-06-15 | ORKA | Sandler Laura Lee | COO | S - Sale | $69.69 | -600 | 236.4K | -0.3% | -$41.8K | |
| 2026-06-15 18:50 | 2026-06-15 | ORKA | Quinlan Paul T | GC | S - Sale | $69.69 | -733 | 31.0K | -2% | -$51.1K | |
| MT | 2026-06-12 16:36 | 2026-06-11+ | ORKA | Dambkowski Carl | Dir | S - Sale | $70.13 | -35.0K | 38.7K | -47% | -$2.45M |
| DMT | 2026-05-22 16:54 | 2026-05-21 | ORKA | Dambkowski Carl | Dir | M - OptEx | $7.95 | +62.3K | 178.7K | +53% | +$494.8K |
| DMT | 2026-05-22 16:54 | 2026-05-21 | ORKA | Dambkowski Carl | Dir | S - Sale+OE | $58.97 | -105.0K | 73.7K | -59% | -$6.19M |
| DMT | 2026-05-18 18:07 | 2026-05-18 | ORKA | Agarwal Arjun | SVP, Fin | M - OptEx | $28.80 | +7,833 | 26.7K | +42% | +$225.6K |
| DMT | 2026-05-18 18:07 | 2026-05-18 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale+OE | $59.07 | -10.3K | 16.4K | -39% | -$607.8K |
| DMT | 2026-05-15 20:17 | 2026-05-15 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 40.4K | +21% | +$51.2K |
| DMT | 2026-05-15 20:17 | 2026-05-15 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $61.85 | -7,000 | 33.4K | -17% | -$432.9K |
| DT | 2026-05-01 18:25 | 2026-05-01 | ORKA | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 242.0K | +2% | +$39.0K |
| DMT | 2026-05-01 18:25 | 2026-05-01 | ORKA | Sandler Laura Lee | COO | S - Sale+OE | $63.88 | -5,000 | 237.0K | -2% | -$319.4K |
| DMT | 2026-04-15 18:45 | 2026-04-15 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 40.4K | +21% | +$51.2K |
| DMT | 2026-04-15 18:45 | 2026-04-15 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $66.12 | -7,000 | 33.4K | -17% | -$462.8K |
| 2026-03-17 | 2026-03-16 | ORKA | Sandler Laura Lee | COO | S - Sale | $41.30 | -600 | 237.0K | -0.3% | -$24.8K | |
| 2026-03-17 | 2026-03-16 | ORKA | Quinlan Paul T | GC | S - Sale | $41.30 | -733 | 31.8K | -2% | -$30.3K | |
| DM | 2026-03-17 | 2026-03-16 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $40.91 | -7,641 | 33.4K | -19% | -$312.6K |
| DM | 2026-03-17 | 2026-03-16 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 37.5K | +23% | +$51.2K |
| 2026-03-17 | 2026-03-16 | ORKA | Klein Lawrence Otto | CEO, Dir | S - Sale | $41.30 | -1,729 | 927.3K | -0.2% | -$71.4K | |
| 2026-03-17 | 2026-03-16 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale | $41.30 | -395 | 18.9K | -2% | -$16.3K | |
| D | 2026-03-02 | 2026-03-02 | ORKA | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 242.6K | +2% | +$39.0K |
| DM | 2026-03-02 | 2026-03-02 | ORKA | Sandler Laura Lee | COO | S - Sale+OE | $33.56 | -5,000 | 237.6K | -2% | -$167.8K |
| DM | 2026-02-17 | 2026-02-17 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 41.0K | +21% | +$51.2K |
| DM | 2026-02-17 | 2026-02-17 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $32.36 | -7,000 | 35.0K | -17% | -$226.5K |
| 2026-01-23 | 2026-01-23 | ORKA | Dambkowski Carl | Dir | J - Other | $0.00 | +116.5K | 116.5K | New | $0 | |
| D | 2026-01-23 | 2026-01-23 | ORKA | Sandler Laura Lee | COO | A - Grant | $0.00 | +32.5K | 237.6K | +16% | $0 |
| D | 2026-01-23 | 2026-01-23 | ORKA | Klein Lawrence Otto | CEO, Dir | A - Grant | $0.00 | +76.7K | 929.0K | +9% | $0 |
| D | 2026-01-23 | 2026-01-23 | ORKA | Quinlan Paul T | GC | A - Grant | $0.00 | +32.5K | 32.5K | New | $0 |
| D | 2026-01-23 | 2026-01-23 | ORKA | Agarwal Arjun | SVP, Fin | A - Grant | $0.00 | +17.5K | 19.3K | +995% | $0 |
| D | 2026-01-23 | 2026-01-23 | ORKA | Goncalves Joana | Chief Medical Off | A - Grant | $0.00 | +32.5K | 34.0K | +2,141% | $0 |
| DM | 2026-01-16 | 2026-01-15 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $31.81 | -7,000 | 4,137 | -63% | -$222.7K |
| DM | 2026-01-16 | 2026-01-15 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 8,518 | +461% | +$51.2K |
| D | 2026-01-02 | 2026-01-02 | ORKA | Sandler Laura Lee | COO | M - OptEx | $7.80 | +5,000 | 218.1K | +2% | +$39.0K |
| DM | 2026-01-02 | 2026-01-02 | ORKA | Sandler Laura Lee | COO | S - Sale+OE | $28.52 | -13.0K | 205.1K | -6% | -$370.8K |
| DM | 2025-12-19 | 2025-12-19 | ORKA | Goncalves Joana | Chief Medical Off | S - Sale+OE | $30.61 | -7,000 | 1,518 | -82% | -$214.3K |
| DM | 2025-12-19 | 2025-12-19 | ORKA | Goncalves Joana | Chief Medical Off | M - OptEx | $7.32 | +7,000 | 8,518 | +461% | +$51.2K |
| I | 2025-09-19 | 2025-09-17 | ORKA | Kiselak Tomas | Dir, 10% | A - Grant | $15.00 | +333.3K | 1.13M | +42% | +$5.00M |
| MI | 2025-02-27 | 2025-02-10+ | ORKA | VHCP Management III, LLC | 10% | P - Purchase | $11.45 | +122.9K | 4.04M | +3% | +$1.41M |
| DI | 2024-11-21 | 2024-11-19 | ORKA | Kiselak Tomas | Dir, 10% | M - OptEx | — | +160.0K | 798.6K | +25% | — |
| DI | 2024-09-13 | 2024-09-11 | ORKA | Kiselak Tomas | Dir, 10% | A - Grant | $23.00 | +275.0K | 638.6K | +76% | +$6.33M |
| MI | 2024-08-20 | 2024-08-16 | ORKA | Janus Henderson Biotech Innovation Master Fund Ltd | 10% | P - Purchase | $2.93 | +5,818 | 2.12M | +0.3% | +$17.1K |
| MI | 2024-07-26 | 2024-07-24+ | ORKA | JANUS HENDERSON GROUP PLC | 10% | P - Purchase | $3.18 | +220.1K | 2.06M | +12% | +$699.1K |
| MI | 2024-07-12 | 2024-07-03+ | ORKA | Janus Henderson Biotech Innovation Master Fund Ltd | 10% | P - Purchase | $3.49 | +408.8K | 1.72M | +31% | +$1.43M |
| D | 2022-12-19 | 2022-12-16 | ORKA | Funicular Funds, LP | 10%, See Footnote 1 | X - OptEx | $2.50 | +1.42M | 4.00M | +55% | +$3.55M |
| 2022-12-09 | 2022-12-08 | ORKA | Keuer Thomas A | COO | A - Grant | $0.00 | +40.0K | 40.7K | +5,479% | $0 | |
| 2022-12-09 | 2022-12-08 | ORKA | Dekker C. Jeffrey | CFO | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 | |
| DI | 2022-07-08 | 2022-07-01 | ORKA | Funicular Funds, LP | 10%, See Footnote 1 | J - Other | $0.00 | -2.58M | 2.58M | -50% | $0 |
| D | 2022-07-08 | 2022-07-01 | ORKA | Funicular Funds, LP | 10%, See Footnote 1 | J - Other | $0.00 | +2.58M | 2.58M | New | $0 |
| M | 2022-05-25 | 2022-05-23+ | ORKA | Ma-Weaver Jacob | See Footnote 1 | P - Purchase | $2.31 | +85.3K | 2.58M | +3% | +$197.2K |
| M | 2022-05-20 | 2022-05-18+ | ORKA | Ma-Weaver Jacob | See Footnote 1 | P - Purchase | $2.30 | +13.1K | 2.50M | +0.5% | +$30.1K |
| M | 2022-05-16 | 2022-05-12+ | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.29 | +84.8K | 2.43M | +4% | +$194.1K |
| M | 2022-05-11 | 2022-05-10+ | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.29 | +45.6K | 2.37M | +2% | +$104.2K |
| M | 2022-05-09 | 2022-05-05+ | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.27 | +124.1K | 2.24M | +6% | +$282.3K |
| M | 2022-05-02 | 2022-04-28+ | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.31 | +33.6K | 2.22M | +2% | +$77.8K |
| D | 2022-04-27 | 2022-04-25 | ORKA | Ma-Weaver Jacob | See Footnote 1 | P - Purchase | $2.29 | +13.8K | 2.19M | +0.6% | +$31.5K |
| D | 2022-04-20 | 2022-04-18 | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.31 | +9,119 | 2.18M | +0.4% | +$21.1K |
| 2022-04-14 | 2022-04-14 | ORKA | Ma-Weaver Jacob | See Footnote 1 | P - Purchase | $2.33 | +17.4K | 2.17M | +0.8% | +$40.6K | |
| M | 2022-04-12 | 2022-04-08+ | ORKA | Ma-Weaver Jacob | See Footnote 1 | P - Purchase | $2.32 | +104.7K | 2.08M | +5% | +$242.6K |
| A | 2022-04-07 | 2022-04-04 | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.26 | +122.3K | 1.94M | +7% | +$276.5K |
| M | 2022-04-07 | 2022-04-05+ | ORKA | Ma-Weaver Jacob | See Footnote 1 | P - Purchase | $2.31 | +104.0K | 2.02M | +5% | +$239.7K |
| 2022-04-04 | 2022-04-04 | ORKA | Funicular Fund, LP | See Footnote 1 | P - Purchase | $2.26 | +122.3K | 1.94M | +7% | +$276.5K | |
| 2021-11-23 | 2021-11-22 | ORKA | Ozeroff Christopher David | SVP, GC | P - Purchase | $2.26 | +50.0K | 51.0K | +5,155% | +$113.0K |
Purchase Sale Sale after option exercise All abbreviations